Antibodies will be the leading class of therapeutics, owing largely to their capability to communicate with distinct ligand conformations so as to elicit distinct biological responses. On the other hand, discovery of new molecules binding distinct epitopes is time-consuming and difficult, specifically for situations necessitating a certain antibody-ligand orientation to https://georgeo777lew9.wiki-racconti.com/user